close

CAR T-Cell Therapy

Bristol Myers Squibb Advances Cell Therapy Portfolio, Bolstering Cancer Treatment

by

Introduction In the relentless fight against cancer and other debilitating diseases, cell therapy has emerged as a beacon of hope, offering innovative and potentially curative treatments. Harnessing the power of living cells to target and destroy disease, cell therapy represents a paradigm shift in medical science. For many patients with hematological malignancies, cell therapies have … Read more

Long-Term Data Solidify CAR T-Cell Therapy as a Durable Treatment for Chronic Lymphocytic Leukemia (CLL)

by

Chronic Lymphocytic Leukemia (CLL), a type of blood cancer that primarily affects older adults, has long presented a complex treatment challenge. For years, CLL patients faced a cycle of treatments, often followed by relapse and the development of resistance to conventional therapies. While advances in chemotherapy and targeted agents offered some hope, the need for … Read more

close